News

AddToAny

Google+ Facebook Twitter Twitter

3D skin imaging

A portable device has been developed that produces high-resolution 3D images of human skin within 
10 minutes.

A team of scientists from Singapore is behind the portable skin mapping device, which they say could be used to assess the severity of skin conditions, such as eczema and psoriasis.

3D skin mapping could be useful to clinicians, as most equipment used to assess skin conditions only provides 2D images of the skin surface.

As the device also maps out the depth of the ridges and grooves of the skin at up to 2mm, it could also help with monitoring wound healing.

The device presses a specially devised film onto the subject’s skin to obtain an imprint of up to 5cm by 5cm, which is then subjected to an electric charge, generating a 3D image.

The researchers designed and 3D-printed a prototype of their device using polylactic acid (PLA), a biodegradable bioplastic. The battery-operated device measures 7cm by 10cm, weighs only 100g and the prototype was developed at a fraction of the cost of devices with comparable technologies.  

bit.ly/3slywGQ

Related Articles

illustration_CREDIT_istock-484714523

Advanced and consultant practice roles

Sarah May and Chris Ward from the IBMS look at advanced and consultant roles and discuss new developments and qualifications.

Robotic hand with handgun aiming in wrong direction. Fatal AI error - Image credit - Shutterstock-2309476357

Tissue contamination distracts AI

In a new study, scientists trained three AI models to scan microscope slides of placenta tissue to detect blood vessel damage, estimate gestational age and classify macroscopic lesions.

Digital pathology cleared for use-history digital pathology-CREDIT-university of warwick

Digital pathology cleared for use

New research has led to the UK government approving the use of digital pathology to help speed up analysis of cancer screening samples.

Breast cancer 3D tomography-CREDIT-Science-Photo-Library-c0303374

Two decades of hHER2 testing

This year marks the 20th anniversary of Her2 breast cancer testing at the Royal Cornwall Hospital. Senior Biomedical Scientist Mary Jones looks back over the past two decades.

Top